Latest Breaking News On - தேசிய அறிவியல் குழு - Page 1 : comparemela.com

Abu Dhabi: The UAE Ministry of Health and Prevention (MoHAP), in collaboration with the Department of Health - Abu Dhabi (DoH) and Dubai Health Authority (DHA), has announced the treatment results for anti-viral medicine Sotrovimab in treating mild to moderate COVID-19 cases among high-risk patients including adults, pregnant women and children aged 12 and above who are at risk of progressing to severe symptoms and meet other relevant criteria. The MoHAP has approved the use of Sotrovimab, which is produced by global biopharmaceutical company GlaxoSmithKline (GSK), after conducting local evaluation. It has also been approved for emergency use by the US Food and Drug Administration.

Ministry of healthUnited arab emiratesUnited statesGulf newsAbu dhabiAbuz abyDubai health authorityDepartment of healthMaryland department of health gulf newsDrug administrationNational scientific committeeImage creditNational scientificMaryland departmentஅமைச்சகம் ஆஃப் ஆரோக்கியம்ஒன்றுபட்டது அரபு அமீரகங்கள்